Cardiometabolic Disorders

Top Story

Age at menarche associated with hypertension, obesity risk

November 20, 2017

Chinese women who experience late menarche are more likely to develop hypertension in adulthood but less likely to develop obesity vs. women who reach menarche at age 14 to 15 years, according to findings reported in Menopause.

Gang Liu, MD, of the department of cardiology at the First Affiliated Hospital of Chongqing Medical University, China, and colleagues analyzed data from 7,119 women (mean age, 45 years) who participated in a cross-sectional study launched in October 2012 and completed in December 2014 in eight rural districts in Chongqing. Participants underwent physical exams and completed a questionnaire about lifestyle habits, age at menarche and previous medical history. Obesity was defined as BMI of at least 28 kg/m²; abdominal obesity was defined as waist circumference at least 80 cm in women. Hypertension was defined as previously diagnosed with or without treatment, or average systolic BP at least 140 mm Hg and/or diastolic BP of least 90 mm Hg. Researchers stratified women by age at menarche (age 11 years or younger, 12 to 13 years, 14 to 15 years, 16 to 17 years and at least 18 years) and birth cohort (born before 1950, born between 1951-1979 and born after 1980). Researchers used binary logistic regression analysis to assess the association between age at menarche, obesity and hypertension, with ORs computed across menarcheal ages.

AMPK activator reduces glucose level in type 2 diabetes in phase 2a trial

November 18, 2017
A novel AMP-activated protein kinase activator showed glucose reduction and decreased cardiovascular risk factors in people with type 2 diabetes in a phase 2a trial…
In the Journals PlusPerspective

Heart failure strongest predictor of poor survival in type 2 diabetes

November 17, 2017
Older adults with type 2 diabetes are at increased risk for death from cardiovascular complications, with the strongest associations found between survival and heart…
Meeting NewsPerspective

Telepharmacy intervention yields modest effect on medication adherence among patients with cardiometabolic diseases

November 15, 2017
ANAHEIM, Calif. — Implementation of a personalized telepharmacy intervention improved medication adherence but did not affect measures of disease control including…
More Headlines »

Understanding and Managing a Complex Dual Dilemma: Diabetes and Dyslipidemia

This activity is supported by an educational grant from Amgen.

Patients with type 2 diabetes have increased cardiovascular risk. Inhibitors of proprotein convertase subtilisin/kexin…
More »
Meeting News

VIDEO: New recommendations made for patients at extreme risk for CVD

July 21, 2017
More »
Resource Centers



Practical Lipidology® (Volume 4): Focus on: LDL Reduction and PCSK9 Inhibition

This activity is supported by an educational grant from Amgen, Inc.

The reduction of low-density lipoprotein cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »